Abstract | BACKGROUND: METHODS: To investigate the effects of TRAIL gene therapy on pancreatic cancer, BxPC-3, MIA-PaCa-2, Panc-1, and ASPC-1 cells were treated with Ad/g-TRAIL. Transfection and protein expression were determined by using immunoblotting and identification of GFP with fluorescent microscopy and flow cytometry. Cell viability was determined by proliferation assay. Cell-cycle analysis and quantification of caspase-3 were used to identify apoptosis. The in vivo efficacy of Ad/g-TRAIL was characterized in a novel red fluorescent protein murine model of MIA-PaCa-2 pancreatic cancer. RESULTS: Cells treated with Ad/g-TRAIL expressed GFP and exhibited apoptotic morphology within 2 days of treatment. Treatment with this vector in vitro resulted in less cell viability, increased caspase-3 activity, and a greater apoptotic fraction than treatment with controls. In vivo, treatment with Ad/g-TRAIL significantly suppressed tumor growth. CONCLUSIONS: TRAIL gene therapy induces apoptosis of pancreatic tumor cells both in vitro and in vivo and is a promising therapy in the treatment of pancreatic cancer.
|
Authors | Matthew H Katz, Daniel E Spivack, Shinako Takimoto, Bingliang Fang, Douglas W Burton, A R Moossa, Robert M Hoffman, Michael Bouvet |
Journal | Annals of surgical oncology
(Ann Surg Oncol)
Vol. 10
Issue 7
Pg. 762-72
(Aug 2003)
ISSN: 1068-9265 [Print] United States |
PMID | 12900367
(Publication Type: Journal Article)
|
Chemical References |
- Apoptosis Regulatory Proteins
- DNA-Binding Proteins
- Luminescent Proteins
- Membrane Glycoproteins
- TNF-Related Apoptosis-Inducing Ligand
- TNFSF10 protein, human
- Tnfsf10 protein, mouse
- Tumor Necrosis Factor-alpha
- red fluorescent protein
- Green Fluorescent Proteins
- Telomerase
- CASP3 protein, human
- Casp3 protein, mouse
- Caspase 3
- Caspases
|
Topics |
- Adenoviridae
- Animals
- Apoptosis Regulatory Proteins
- Blotting, Western
- Carcinoma, Pancreatic Ductal
(therapy)
- Caspase 3
- Caspases
(metabolism)
- Catalytic Domain
- DNA-Binding Proteins
- Genes, Transgenic, Suicide
- Genetic Therapy
- Green Fluorescent Proteins
- Humans
- Insect Vectors
- Luminescent Proteins
(metabolism, therapeutic use)
- Membrane Glycoproteins
(therapeutic use)
- Mice
- Pancreatic Neoplasms
(therapy)
- TNF-Related Apoptosis-Inducing Ligand
- Telomerase
(therapeutic use)
- Transfection
- Tumor Cells, Cultured
- Tumor Necrosis Factor-alpha
(therapeutic use)
|